Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Dynastat“
Suchtreffer
Begriffe & Kennungen
Dynastat · 4.5 · Plasma exposure (AUC and Cmax) to valdecoxib was increased (38% and 24%, respectively) when coadministered wit
Eintrag öffnenDynastat · 4.5 · Plasma exposure (AUC and Cmax) to valdecoxib was increased (62% and 19%, respectively) when coadministered wit
Eintrag öffnenDynastat · 4.5 · Plasma exposure (AUC and Cmax) to valdecoxib was increased (62% and 19%, respectively) when coadministered wit
Eintrag öffnenDynastat · 4.5 · Plasma exposure of omeprazole (CYP 2C19 substrate) 40 mg once daily was increased by 46% following administrat
Eintrag öffnenDynastat · 4.5 · Plasma exposure of omeprazole (CYP 2C19 substrate) 40 mg once daily was increased by 46% following administrat
Eintrag öffnenDynastat · 4.5 · The effect of enzyme induction has not been studied. The metabolism of valdecoxib may increase when coadminist
Eintrag öffnenDynastat · 4.5 · The effect of enzyme induction has not been studied. The metabolism of valdecoxib may increase when coadminist
Eintrag öffnenDynastat · 4.5 · Therefore, the concomitant administration of these drugs should be done with caution. Patients should be adequ
Eintrag öffnenDynastat · 4.6 Fertility, pregnancy, and lactation · 1
Eintrag öffnenDynastat · 4.6 Fertility, pregnancy, and lactation · 2
Eintrag öffnenDynastat · 4.8 Undesirable effects · 1
Eintrag öffnenDynastat · 4.8 Undesirable effects · 2
Eintrag öffnenDynastat · 4.8 · 10 Adverse Drug Reaction Frequency Very Common Common Uncommon Rare (1/10,000 Not known (1/10) (1/100 to (
Eintrag öffnenDynastat · 4.8 · 26 Adverse Drug Reaction Frequency Very Common Common Uncommon Rare (1/10,000 Not known (1/10) (1/100 to (
Eintrag öffnenDynastat · 4.8 · 9 Adverse Drug Reaction Frequency Very Common Common Uncommon Rare (1/10,000 Not known (1/10) (1/100 to (1
Eintrag öffnenDynastat · 4.8 · Adverse Drug Reaction Frequency Very Common Common Uncommon Rare (1/10,000 Not known (1/10) (1/100 to (1/1
Eintrag öffnenDynastat · 4.8 · Adverse Drug Reaction Frequency Very Common Common Uncommon Rare (1/10,000 Not known (1/10) (1/100 to (1/1
Eintrag öffnenDynastat · 4.8 · Description of selected adverse reactions In post-marketing experience, toxic epidermal necrolysis has been re
Eintrag öffnenDynastat · 4.8 · Description of selected adverse reactions In post-marketing experience, toxic epidermal necrolysis has been re
Eintrag öffnenDynastat · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnen